Morgan Stanley Adagio Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 357,430 shares of ADGI stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

357,430

Previous 244,090 46.43%

Holding current value

$1.18 Million

Previous $807,000 46.59%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	N/A	113,340 Added 46.43%	357,430 $1.18 Million
Q2 2024 Oct 17, 2024	BUY	N/A	184,561 Added 310.04%	244,090 $807,000
Q2 2024 Aug 14, 2024	BUY	N/A	184,561 Added 310.04%	244,090 $807,000
Q1 2024 Oct 17, 2024	SELL	N/A	-184,561 Reduced 75.61%	59,529 $197,000
Q1 2024 Aug 16, 2024	BUY	N/A	54,314 Added 1041.5%	59,529 $197,000
Q1 2024 May 15, 2024	BUY	N/A	54,314 Added 1041.5%	59,529 $197,000
Q4 2023 Aug 16, 2024	SELL	N/A	-238,875 Reduced 97.86%	5,215 $17,000
Q4 2023 Feb 13, 2024	SELL	N/A	-29,956 Reduced 85.17%	5,215 $17,000
Q3 2023 Nov 15, 2023	SELL	N/A	-45,148 Reduced 56.21%	35,171 $116,000
Q2 2023 Aug 14, 2023	BUY	N/A	17,839 Added 28.55%	80,319 $265,000
Q1 2023 May 15, 2023	BUY	N/A	17,111 Added 37.72%	62,480 $206,000
Q4 2022 Feb 14, 2023	BUY	$3.08 - $4.05 $92,729 - $121,933	30,107 Added 197.27%	45,369 $150,000
Q3 2022 Nov 14, 2022	SELL	$2.97 - $4.83 $25,105 - $40,827	-8,453 Reduced 35.64%	15,262 $47,000
Q2 2022 Oct 27, 2022	SELL	$2.54 - $4.52 $94,851 - $168,790	-37,343 Reduced 61.16%	23,715 $78,000
Q2 2022 Aug 15, 2022	SELL	$2.54 - $4.52 $94,851 - $168,790	-37,343 Reduced 61.16%	23,715 $78,000
Q1 2022 Oct 27, 2022	BUY	$3.81 - $10.77 $142,276 - $402,184	37,343 Added 157.47%	61,058 $278,000
Q1 2022 May 13, 2022	BUY	$3.81 - $10.77 $7,490 - $21,173	1,966 Added 3.33%	61,058 $278,000
Q4 2021 Feb 14, 2022	BUY	$6.35 - $47.04 $284,734 - $2.11 Million	44,840 Added 314.62%	59,092 $430,000
Q3 2021 Nov 15, 2021	BUY	$20.88 - $56.08 $297,581 - $799,252	14,252 New	14,252 $602,000

Others Institutions Holding ADGI

# of Institutions

Shares Held

63.9M

Call Options Held

2.3K

Put Options Held

2.1K

View Full List

About Adagio Therapeutics, Inc.

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

More about ADGI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account